Insiders · Profile

Christopher Nishan Garabedian

President and CEO at Sarepta Therapeutics. Filing since 6 Apr 2011. CIK 0001492604

Company
Date
Role
Action
Shares
Amount
Of holding
27 Feb 2015
President and CEO
Bought
800
$9.45K
2.8%
15 Dec 2011
President and CEO
Bought
300,000
$173.64K
231%
6 Apr 2011
President and CEO
Bought
130,000
$195.00K
opened
3 decisions on file.